Reuters logo
4 个月前
BRIEF-Nativis enters into licensing agreement for Glioblastoma Multiforme in Japan
2017年4月4日 / 中午12点17分 / 4 个月前

BRIEF-Nativis enters into licensing agreement for Glioblastoma Multiforme in Japan

April 4 (Reuters) - Teijin Ltd

* Nativis enters into exclusive licensing agreement for Glioblastoma Multiforme in Japan

* Under terms of agreement, Teijin will receive an exclusive license to Nativis Voyager System for indication of GBM in Japan

* Co to receive an undisclosed upfront payment, payments based on achievement of specific milestones, royalties on sales of product in Japan

* Co, Teijin anticipate to continue discussions for potential licensing opportunities of Nativis ULRFE technology for other indications in Japan Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below